These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8780167)

  • 21. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide.
    Konturek PC; Brzozowski T; Walter B; Burnat G; Hess T; Hahn EG; Konturek SJ
    Eur J Pharmacol; 2006 Apr; 536(1-2):171-81. PubMed ID: 16581065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
    Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ
    Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.
    Narita I; Border WA; Ketteler M; Noble NA
    Lab Invest; 1995 Jan; 72(1):17-24. PubMed ID: 7837786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation.
    Yuksel BC; Tanriverdi P; Ozel H; Avsar FM; Topaloglu S; Iskit AB
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxix-ccxxi. PubMed ID: 15244184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of capillary growth in chronically stimulated rat muscles by N(G)-nitro-l-arginine, nitric oxide synthase inhibitor.
    Hudlická O; Brown MD; Silgram H
    Microvasc Res; 2000 Jan; 59(1):45-51. PubMed ID: 10625570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
    Schlaich MP; Schmitt D; Ott C; Schmidt BM; Schmieder RE
    J Hypertens; 2008 Jan; 26(1):110-6. PubMed ID: 18090547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt and nitric oxide inhibition induced hypertension: the role of prostacycline and 8-isoprostane.
    Ilhan S; Oktar S; Sahna E; Aksulu HE
    Clin Exp Hypertens; 2011; 33(2):84-8. PubMed ID: 21214402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
    Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
    Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature.
    Bertuglia S; Colantuoni A; Intaglietta M
    Microvasc Res; 1995 Sep; 50(2):162-74. PubMed ID: 8538497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection.
    Vos IH; Joles JA; Schurink M; Weckbecker G; Stojanovic T; Rabelink TJ; Gröne HJ
    Eur J Pharmacol; 2000 Mar; 391(1-2):31-8. PubMed ID: 10720632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat.
    Cattell V; Smith J; Jansen A; Riveros-Moreno V; Moncada S
    Transplantation; 1994 Dec; 58(12):1399-402. PubMed ID: 7528951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation.
    Duijvestijn AM; van Breda Vriesman PJ
    Transplantation; 1991 Aug; 52(2):195-202. PubMed ID: 1871789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II.
    Deng A; Miracle CM; Suarez JM; Lortie M; Satriano J; Thomson SC; Munger KA; Blantz RC
    Kidney Int; 2005 Aug; 68(2):723-30. PubMed ID: 16014049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition.
    Verhagen AM; Rabelink TJ; Braam B; Opgenorth TJ; Gröne HJ; Koomans HA; Joles JA
    J Am Soc Nephrol; 1998 May; 9(5):755-62. PubMed ID: 9596072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy.
    Neto JS; Nakao A; Toyokawa H; Nalesnik MA; Romanosky AJ; Kimizuka K; Kaizu T; Hashimoto N; Azhipa O; Stolz DB; Choi AM; Murase N
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F324-34. PubMed ID: 16131650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic inhibition of nitric oxide synthase activity by NG-nitro-L-arginine induces nitric oxide synthase expression in the developing rat cerebellum.
    Serfőző Z; Lontay B; Kukor Z; Erdődi F
    Neurochem Int; 2012 May; 60(6):605-15. PubMed ID: 22391324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow.
    Natori Y; Moriguchi M; Fujiwara S; Takeshita I; Fukui M; Iwaki T; Kanaide H
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):120-7. PubMed ID: 1727133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.
    Gröne HJ; Weber C; Weber KS; Gröne EF; Rabelink T; Klier CM; Wells TN; Proudfood AE; Schlöndorff D; Nelson PJ
    FASEB J; 1999 Aug; 13(11):1371-83. PubMed ID: 10428761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.